The Immunomodulatory Role of Angiocidin, a Novel Angiogenesis Inhibitor

By  

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-06 ,pp. : 1937-1948

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma

By Wong Chi   Loong Herbert   Hui Connie   Lau Cecilia   Hui Edwin   Ma Brigette   Chan Anthony  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1399-1408

Springer Publishing Company

Access to resources Recommend Favorite

Preparation and anticoagulant activity of the phosphosulfomannan PI-88

By Yu G.   Gunay N.S.   Linhardt R.J.   Toida T.   Fareed J.   Hoppensteadt D.A.   Shadid H.   Ferro V.   Li C.   Fewings K.   Palermo M.C.   Podger D.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 10, 2002-10 ,pp. : 783-791

Elsevier

Access to resources Recommend Favorite

TNP-470: an angiogenesis inhibitor in clinical development for cancer

By Kruger E.A.   Figg W.D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1383-1396

Informa Healthcare

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of angiogenesis

By Cooke John  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite